MindWalk Holdings Corp. (HYFT) provides Q2 MD&A and financials update

Rhea-AI Filing Summary

MindWalk Holdings Corp. filed a Form 6-K as a foreign private issuer, furnishing updated quarterly information for investors. The filing includes Management’s Discussion and Analysis and Condensed Interim Consolidated Financial Statements for the three and six months ended October 31, 2025 and 2024, giving more detail on the company’s recent operating and financial performance.

The filing also states that Exhibits 99.1 and 99.2 are incorporated by reference into MindWalk’s existing registration statements on Form S-8 and Form F-3, which relate to previously registered securities. In addition, CEO and CFO certifications pursuant to Canadian regulations are provided as Exhibits 99.3 and 99.4, and the report is signed on behalf of the company by Chief Executive Officer Jennifer Bath.

Q2October 31, 2025false0001715925--04-300001715925ifrs-full:LaterThanFiveYearsMember2025-10-310001715925ifrs-full:LeaseLiabilitiesMember2025-05-012025-10-310001715925hyft:LabEquipmentMember2025-10-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:OptionSixAndSevenMember2025-10-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-08-012025-10-310001715925hyft:AllOtherCountriesMember2024-05-012024-10-310001715925hyft:OfficersAndEmployeesMemberhyft:ThreeAugustTwentyTwentyFourMember2025-10-310001715925ifrs-full:TopOfRangeMemberhyft:LabAndOfficeFacilitiesMember2025-05-012025-10-310001715925country:NL2025-10-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2025-05-012025-10-310001715925hyft:OptionThreeMember2025-05-012025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925ifrs-full:RetainedEarningsMember2024-04-3000017159252024-08-012024-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-05-012024-10-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2025-05-012025-10-310001715925hyft:NetBookValueMemberhyft:LabEquipmentMember2025-04-3000017159252024-10-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-10-310001715925hyft:OptionFourteenMember2025-05-012025-10-310001715925ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2025-05-012025-10-310001715925country:BE2025-05-012025-10-310001715925hyft:NetBookValueMemberhyft:CertificationsMember2025-10-310001715925srt:EuropeMember2025-05-012025-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-10-310001715925hyft:FindersWarrantsMember2024-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-05-012025-10-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2024-04-300001715925hyft:FindersWarrantsMember2025-05-012025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-10-310001715925hyft:AccumulatedDepreciationAmountMember2025-10-310001715925hyft:OptionThirteenMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-04-300001715925ifrs-full:RestrictedShareUnitsMember2025-05-012025-10-310001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2024-05-012025-04-300001715925hyft:FindersWarrantsMember2025-04-300001715925hyft:DeferredAcquisitionPaymentsMember2025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-07-310001715925hyft:OptionFourMember2025-05-012025-10-310001715925ifrs-full:PotentialOrdinaryShareTransactionsMemberifrs-full:TopOfRangeMemberhyft:ConvertibleDebenturesMemberhyft:AtTheMarketEquityOfferingFacilityMember2025-11-072025-11-070001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2025-05-012025-10-310001715925ifrs-full:RetainedEarningsMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2024-05-012025-04-3000017159252024-07-310001715925ifrs-full:WeightedAverageMemberhyft:LabEquipmentMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:OptionFourteenMember2025-10-310001715925ifrs-full:IssuedCapitalMember2025-08-012025-10-310001715925hyft:OptionEightMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2025-10-310001715925hyft:LabAndOfficeFacilitiesMember2025-10-310001715925hyft:AllOtherCountriesMember2024-08-012024-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-10-310001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2025-04-300001715925hyft:ProjectRevenueMember2025-08-012025-10-310001715925ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2025-10-310001715925country:CA2025-05-012025-10-3100017159252025-05-012025-10-310001715925country:CA2024-05-012024-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2024-04-300001715925country:NL2024-08-012024-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2024-05-012025-04-300001715925hyft:OptionNineteenMember2025-05-012025-10-310001715925country:AU2024-05-012024-10-310001715925ifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925hyft:OptionTwelveMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-05-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-10-310001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2025-04-300001715925hyft:AccumulatedDepreciationAmountMember2025-05-012025-10-310001715925hyft:ProjectRevenueMember2024-05-012024-10-310001715925ifrs-full:VehiclesMemberhyft:AccumulatedDepreciationAmountMember2025-04-300001715925hyft:MindWalkBiologicsMember2025-05-012025-10-310001715925hyft:OptionSeventeenMember2025-05-012025-10-310001715925hyft:DeferredAcquisitionPaymentsMember2024-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-05-012025-10-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2024-05-012025-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-05-012025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-08-012025-10-310001715925ifrs-full:RestrictedShareUnitsMember2025-10-3100017159252023-05-012024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012025-10-310001715925ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2025-10-310001715925hyft:OptionNineMember2025-10-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2024-05-012025-04-300001715925hyft:OptionFifteenMember2025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2025-05-012025-10-310001715925hyft:AllOtherCountriesMember2025-08-012025-10-310001715925hyft:IdeaFamilyB.vMember2024-03-012025-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:NetBookValueMember2025-10-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-10-310001715925hyft:OptionSixteenMember2025-05-012025-10-3100017159252024-05-012024-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2024-04-300001715925ifrs-full:IssuedCapitalMemberifrs-full:OrdinarySharesMember2024-05-012025-04-300001715925srt:EuropeMember2024-05-012024-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2024-05-012025-04-3000017159252024-04-300001715925hyft:DeferredAcquisitionPaymentsMember2025-10-310001715925ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2025-10-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2024-04-300001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-10-310001715925hyft:OptionEightMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:OptionEighteenMember2025-05-012025-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:MindWalkBVMember2025-05-012025-10-310001715925hyft:OptionSixteenMember2025-10-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925country:BE2024-08-012024-10-310001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925country:NL2025-05-012025-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2024-04-300001715925hyft:ProductSalesMember2024-08-012024-10-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-07-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2024-05-012025-04-300001715925ifrs-full:DiscontinuedOperationsMember2024-08-012024-10-310001715925ifrs-full:DiscontinuedOperationsMember2025-05-012025-10-310001715925country:CA2025-08-012025-10-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2025-10-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925hyft:DebenturesMember2024-04-300001715925hyft:AllOtherCountriesMember2025-05-012025-10-310001715925hyft:MindWalkBVMember2024-03-012025-04-300001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2025-10-310001715925hyft:DebenturesMember2024-05-012024-10-310001715925country:BE2025-04-300001715925ifrs-full:TopOfRangeMemberhyft:LabEquipmentMember2025-05-012025-10-310001715925hyft:OptionNineteenMember2025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-10-310001715925country:AU2025-08-012025-10-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:TalemTherapeuticsLLCTalemMember2025-05-012025-10-310001715925hyft:CryoStorageMember2025-08-012025-10-310001715925ifrs-full:LeaseLiabilitiesMember2024-05-012024-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2025-10-310001715925ifrs-full:RetainedEarningsMember2024-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2024-05-012025-04-300001715925hyft:OptionThirteenMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-05-012025-10-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:FindersWarrantsMember2023-05-012024-04-300001715925hyft:ConvertibleDebenturesMemberhyft:YaIiPnLtdMemberhyft:TrancheTwoMember2024-07-160001715925hyft:OptionFiveMember2025-10-310001715925srt:EuropeMember2025-08-012025-10-310001715925hyft:DeferredAcquisitionPaymentsMember2024-04-300001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2024-03-012025-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2024-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-05-012025-10-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:RetainedEarningsMember2024-05-012024-10-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2024-05-012025-04-300001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925country:BE2025-10-310001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2025-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2024-04-300001715925ifrs-full:IssuedCapitalMember2024-04-300001715925hyft:MindWalkBiologicsMember2024-03-012025-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2024-05-012024-10-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2024-04-300001715925ifrs-full:TopOfRangeMemberhyft:AtTheMarketEquityOfferingFacilityMember2024-07-292024-07-290001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:AccumulatedDepreciationAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2024-05-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-05-012024-10-310001715925hyft:BiokeyB.vMember2024-03-012025-04-300001715925hyft:OptionTwentyMember2025-05-012025-10-310001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-10-310001715925hyft:IdeaFamilyB.vMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2025-10-310001715925country:US2025-05-012025-10-310001715925ifrs-full:AdditionalPaidinCapitalMember2024-08-012024-10-310001715925ifrs-full:RetainedEarningsMember2025-07-310001715925hyft:CryoStorageMember2024-08-012024-10-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2024-05-012025-04-300001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:IssuedCapitalMember2024-08-012024-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2025-04-300001715925hyft:OptionOneMember2025-05-012025-10-310001715925country:CA2024-08-012024-10-310001715925country:BE2025-08-012025-10-310001715925ifrs-full:NotLaterThanOneYearMember2025-10-310001715925ifrs-full:DiscontinuedOperationsMember2025-08-012025-10-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925ifrs-full:RestrictedShareUnitsMember2024-05-012025-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2024-05-012025-04-300001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012025-10-310001715925hyft:DeferredAcquisitionPaymentsMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925country:US2024-08-012024-10-310001715925country:BE2024-05-012024-10-310001715925hyft:DebenturesMember2024-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-05-012025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-04-300001715925ifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2025-10-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2024-05-012025-04-300001715925hyft:ProductSalesMember2025-05-012025-10-310001715925hyft:BiokeyB.vMember2025-05-012025-10-310001715925hyft:OptionTwelveMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-10-310001715925ifrs-full:IssuedCapitalMember2025-04-300001715925hyft:ConvertibleDebenturesMemberhyft:YaIiPnLtdMemberhyft:TrancheOneMember2024-07-160001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2025-10-310001715925ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2025-10-310001715925ifrs-full:RetainedEarningsMember2024-10-310001715925hyft:CryoStorageMember2025-05-012025-10-310001715925hyft:NetBookValueMemberhyft:AutomobileMember2025-10-310001715925ifrs-full:RestrictedShareUnitsMember2024-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-10-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2025-04-300001715925country:NL2024-05-012024-10-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925srt:NorthAmericaMember2024-05-012024-10-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2024-03-012025-04-300001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2025-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-10-310001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2025-05-012025-10-310001715925hyft:NetBookValueMember2025-10-310001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2024-05-012025-04-300001715925hyft:OptionNineToTwentyMember2025-10-310001715925hyft:ConvertibleDebenturesMemberhyft:YaIiPnLtdMember2024-07-160001715925ifrs-full:RetainedEarningsMember2025-08-012025-10-310001715925hyft:ProjectRevenueMember2024-08-012024-10-310001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-05-012025-10-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925hyft:OptionTwentyMember2025-10-310001715925hyft:OptionEighteenMember2025-10-310001715925hyft:NetBookValueMemberhyft:CertificationsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-04-300001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925ifrs-full:LeaseLiabilitiesMember2024-04-300001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2025-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-04-300001715925hyft:ProjectRevenueMember2025-05-012025-10-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-05-012025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-04-300001715925ifrs-full:TopOfRangeMemberhyft:AtTheMarketEquityOfferingFacilityMember2024-02-232024-02-230001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2024-04-300001715925hyft:RangeTwoMemberhyft:FindersWarrantsMember2025-10-310001715925ifrs-full:BottomOfRangeMemberifrs-full:VehiclesMember2025-05-012025-10-310001715925ifrs-full:IssuedCapitalMember2025-05-012025-10-310001715925ifrs-full:BottomOfRangeMemberhyft:LabAndOfficeFacilitiesMember2025-05-012025-10-3100017159252025-04-300001715925ifrs-full:IssuedCapitalMember2024-10-310001715925hyft:ImmunoPreciseAntibodiesMALLCMember2025-05-012025-10-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2024-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2024-05-012025-04-300001715925country:US2024-05-012024-10-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:NetBookValueMember2025-04-300001715925ifrs-full:IssuedCapitalMember2024-05-012024-10-310001715925hyft:MindWalkBVMember2024-10-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-05-012025-10-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925ifrs-full:IssuedCapitalMember2024-07-310001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-10-310001715925country:AU2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-04-300001715925country:AU2024-08-012024-10-310001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-10-310001715925country:NL2025-08-012025-10-310001715925hyft:ImmunoPreciseAntibodiesEuropeBVIPAEuropeFormerlyModiQuestResearchBVMember2025-05-012025-10-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2024-04-300001715925hyft:DeferredAcquisitionPaymentsMember2024-05-012024-10-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925ifrs-full:LeaseLiabilitiesMember2024-10-3100017159252025-08-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2024-05-012025-04-300001715925hyft:ImmunoPreciseAntibodiesEuropeBVIPAEuropeFormerlyModiQuestResearchBVMember2024-03-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2024-04-300001715925ifrs-full:VehiclesMember2025-10-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-04-300001715925ifrs-full:RetainedEarningsMember2024-08-012024-10-310001715925hyft:OptionSevenMember2025-10-310001715925ifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-04-300001715925ifrs-full:RetainedEarningsMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-05-012025-10-310001715925hyft:OptionFifteenMember2025-05-012025-10-310001715925hyft:BioclueB.vMember2025-05-012025-10-310001715925hyft:NetBookValueMemberhyft:LabEquipmentMember2025-10-310001715925hyft:RangeTwoMemberhyft:FindersWarrantsMember2025-05-012025-10-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2025-04-300001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2025-10-310001715925ifrs-full:VehiclesMemberifrs-full:WeightedAverageMember2025-05-012025-10-310001715925hyft:NetBookValueMemberifrs-full:CustomerrelatedIntangibleAssetsMember2025-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2024-05-012025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2024-04-300001715925hyft:NetBookValueMemberifrs-full:VehiclesMember2025-10-310001715925ifrs-full:IssuedCapitalMemberifrs-full:OrdinarySharesMember2025-04-300001715925hyft:ImmunoPreciseNetherlandsBVMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-10-310001715925hyft:NetBookValueMemberifrs-full:VehiclesMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2025-04-300001715925ifrs-full:DiscontinuedOperationsMember2025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-10-310001715925srt:NorthAmericaMember2024-08-012024-10-310001715925ifrs-full:IssuedCapitalMember2025-07-310001715925hyft:OptionSeventeenMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-05-012025-10-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-05-012025-10-310001715925hyft:ImmunoPreciseAntibodiesMALLCMember2024-03-012025-04-300001715925country:NL2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-05-012025-10-310001715925hyft:OfficersAndEmployeesMemberhyft:ThreeAugustTwentyTwentyFourMember2025-05-012025-10-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925srt:EuropeMember2024-08-012024-10-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-10-310001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2024-04-300001715925srt:NorthAmericaMember2025-08-012025-10-310001715925hyft:NetBookValueMemberhyft:AutomobileMember2025-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2025-05-012025-10-310001715925hyft:TalemTherapeuticsLLCTalemMember2024-03-012025-04-300001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2024-04-300001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2025-04-300001715925hyft:LabAndOfficeFacilitiesMemberifrs-full:WeightedAverageMember2025-05-012025-10-310001715925hyft:AccumulatedDepreciationAmountMember2024-04-300001715925hyft:OptionOneMember2025-10-310001715925hyft:BioclueB.vMember2024-03-012025-04-300001715925srt:NorthAmericaMember2025-10-310001715925hyft:ProductSalesMember2025-08-012025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-08-012024-10-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:OptionThreeMember2025-10-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:OptionSevenMember2025-05-012025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:OptionNineMember2025-05-012025-10-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2025-10-310001715925hyft:OptionElevenMember2025-05-012025-10-310001715925srt:NorthAmericaMember2025-04-300001715925hyft:OptionSixMember2025-05-012025-10-310001715925hyft:ProductSalesMember2024-05-012024-10-3100017159252025-07-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2024-04-300001715925ifrs-full:RestrictedShareUnitsMember2025-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2024-04-300001715925srt:NorthAmericaMember2025-05-012025-10-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925hyft:FindersWarrantsMember2025-10-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2025-10-310001715925hyft:CryoStorageMember2024-05-012024-10-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-04-300001715925ifrs-full:IssuedCapitalMember2025-10-310001715925ifrs-full:GrossCarryingAmountMember2025-10-310001715925ifrs-full:BottomOfRangeMemberhyft:LabEquipmentMember2025-05-012025-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2024-04-300001715925ifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-10-310001715925hyft:OptionFiveMember2025-05-012025-10-310001715925hyft:OptionSixMember2025-10-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2025-05-012025-10-310001715925hyft:OptionTenMember2025-10-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2025-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925hyft:OptionFourMember2025-10-3100017159252022-05-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-05-012025-10-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925hyft:OptionTwoMember2025-10-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-05-012025-10-310001715925hyft:ImmunoPreciseNetherlandsBVMember2024-03-012025-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-05-012025-10-310001715925ifrs-full:DiscontinuedOperationsMember2024-05-012024-10-310001715925ifrs-full:LeaseLiabilitiesMember2025-10-310001715925ifrs-full:RetainedEarningsMember2025-04-300001715925hyft:AccumulatedDepreciationAmountMember2024-05-012025-04-300001715925hyft:OptionTwoMember2025-05-012025-10-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925country:US2025-08-012025-10-310001715925ifrs-full:LeaseLiabilitiesMember2025-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-08-012025-10-310001715925hyft:OptionElevenMember2025-10-310001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2025-04-300001715925hyft:FindersWarrantsMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2024-05-012025-04-3000017159252025-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-07-3100017159252024-05-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-10-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2024-08-012024-10-310001715925hyft:OptionTenMember2025-05-012025-10-31iso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:sharesiso4217:CADiso4217:CADxbrli:sharesiso4217:USDutr:Y

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of December, 2025.

Commission File Number: 001-39530

MindWalk Holdings Corp.

3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INCORPORATION BY REFERENCE

Exhibits 99.1 and 99.2 of this Form 6-K are incorporated by reference into the Registration Statements on Form S-8 (File Nos. 333-256730 and 333-290949) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312) of the Registrant, MindWalk Holdings Corp.

EXHIBIT INDEX

Exhibit	Description
99.1	Management’s Discussion and Analysis for the three and six months ended October 31, 2025 and 2024
99.2	Condensed Interim Consolidated Financial Statements for the three and six months ended October 31, 2025 and 2024
99.3	CEO Certification (pursuant to Canadian regulations)
99.4	CFO Certification (pursuant to Canadian regulations)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MINDWALK HOLDINGS CORP.
Date: December 15, 2025
	By:	/s/ Jennifer Bath
	Name:	Jennifer Bath
	Title:	Chief Executive Officer

FAQ

What period does MindWalk Holdings Corp. (HYFT) cover in its latest Form 6-K filing?

The filing covers the three and six months ended October 31, 2025 and 2024, with Management’s Discussion and Analysis and Condensed Interim Consolidated Financial Statements for those periods.

What key documents are attached to MindWalk Holdings Corp. (HYFT) December 2025 Form 6-K?

The Form 6-K includes Exhibit 99.1 (Management’s Discussion and Analysis), Exhibit 99.2 (Condensed Interim Consolidated Financial Statements), plus Exhibits 99.3 and 99.4 containing CEO and CFO certifications pursuant to Canadian regulations.

How does the latest MindWalk Holdings Corp. (HYFT) Form 6-K relate to its existing registration statements?

The filing states that Exhibits 99.1 and 99.2 are incorporated by reference into MindWalk’s Registration Statements on Form S-8 (File Nos. 333-256730 and 333-290949) and Form F-3 (File Nos. 333-273197 and 333-281312).

Who signed MindWalk Holdings Corp. (HYFT) December 2025 Form 6-K?

The report was signed on behalf of MindWalk Holdings Corp. by Jennifer Bath, who is identified as the company’s Chief Executive Officer.

What type of issuer is MindWalk Holdings Corp. (HYFT) in this SEC filing?

MindWalk Holdings Corp. files this report as a foreign private issuer using Form 6-K under the Securities Exchange Act of 1934.

Where is MindWalk Holdings Corp. (HYFT) headquartered according to the Form 6-K?

The company’s principal executive office is listed as 3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8.